Bio-Rad Laboratories, Inc.
BIO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,844,200 | -$637,300 | -$3,627,500 | $4,254,300 |
| Dep. & Amort. | $151,600 | $145,900 | $137,300 | $137,600 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $62,300 | $61,300 | $60,900 | $51,200 |
| Change in WC | -$620,800 | -$432,800 | -$1,610,000 | $1,143,100 |
| Other Non-Cash | $2,706,300 | $1,237,843 | $5,233,747 | -$4,916,736 |
| Operating Cash Flow | $455,200 | $374,943 | $194,447 | $669,464 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$165,600 | -$156,680 | -$112,782 | -$133,746 |
| Net Acquisitions | $0 | $2,500 | -$99,386 | -$125,516 |
| Inv. Purchases | -$1,276,600 | -$689,041 | -$2,060,238 | -$851,627 |
| Inv. Sales/Matur. | $1,305,300 | $863,218 | $1,066,027 | $766,896 |
| Other Inv. Act. | -$23,300 | $211 | -$1,214 | -$453,388 |
| Investing Cash Flow | -$160,200 | $20,208 | -$1,207,593 | -$797,381 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$400 | -$467 | $1,185,710 | -$3,020 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$203,600 | -$428,728 | -$215,679 | -$49,998 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$14,800 | $3,548 | $3,545 | -$2,411 |
| Financing Cash Flow | -$218,800 | -$425,647 | $973,576 | -$55,429 |
| Forex Effect | $9,200 | $321 | $2,981 | -$12,636 |
| Net Chg. in Cash | $85,400 | -$30,175 | -$36,589 | -$195,982 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $404,400 | $434,544 | $471,133 | $667,115 |
| End Cash | $489,800 | $404,369 | $434,544 | $471,133 |
| Free Cash Flow | $266,200 | $218,263 | $80,290 | $535,718 |